Lena Ho

7.7k total citations · 4 hit papers
37 papers, 5.0k citations indexed

About

Lena Ho is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lena Ho has authored 37 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Pharmacology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lena Ho's work include Apelin-related biomedical research (9 papers), Chromatin Remodeling and Cancer (8 papers) and Genomics and Chromatin Dynamics (6 papers). Lena Ho is often cited by papers focused on Apelin-related biomedical research (9 papers), Chromatin Remodeling and Cancer (8 papers) and Genomics and Chromatin Dynamics (6 papers). Lena Ho collaborates with scholars based in United States, Singapore and Australia. Lena Ho's co-authors include Robert H. Crabtree, Jeffrey A. Ranish, H. Courtney Hodges, Laura Elias, Cigall Kadoch, Diana C. Hargreaves, Bruno Reversade, Jehnna L. Ronan, Serene C. Chng and Jing Tian and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Lena Ho

37 papers receiving 4.9k citations

Hit Papers

Proteomic and bioinformatic analysis of mammalian SWI/SNF... 2010 2026 2015 2020 2013 2010 2010 2013 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lena Ho United States 23 3.7k 700 699 653 628 37 5.0k
Bruno Reversade Singapore 32 3.0k 0.8× 382 0.5× 140 0.2× 876 1.3× 965 1.5× 87 4.4k
Iris Albert United States 15 6.4k 1.7× 1.0k 1.4× 1.3k 1.8× 122 0.2× 365 0.6× 16 8.3k
Valérie Ferreira Netherlands 22 3.4k 0.9× 685 1.0× 101 0.1× 182 0.3× 421 0.7× 30 5.0k
Rafael Espinosa United States 35 2.7k 0.7× 916 1.3× 286 0.4× 106 0.2× 386 0.6× 67 4.9k
Jeffrey E. Ming United States 28 1.9k 0.5× 990 1.4× 237 0.3× 159 0.2× 548 0.9× 68 5.4k
Teresa Druck United States 41 5.1k 1.4× 728 1.0× 387 0.6× 83 0.1× 324 0.5× 87 6.8k
Andrea Brendolan Italy 22 1.6k 0.4× 1.5k 2.1× 462 0.7× 68 0.1× 354 0.6× 35 3.5k
Dani Bercovich Israel 28 1.2k 0.3× 230 0.3× 505 0.7× 78 0.1× 284 0.5× 74 2.9k
Corey T. Watson United States 30 1.6k 0.4× 1.3k 1.9× 596 0.9× 106 0.2× 105 0.2× 90 3.5k
Marco López-Ilasaca United States 23 1.6k 0.4× 415 0.6× 151 0.2× 86 0.1× 512 0.8× 27 2.9k

Countries citing papers authored by Lena Ho

Since Specialization
Citations

This map shows the geographic impact of Lena Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lena Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lena Ho more than expected).

Fields of papers citing papers by Lena Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lena Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lena Ho. The network helps show where Lena Ho may publish in the future.

Co-authorship network of co-authors of Lena Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Lena Ho. A scholar is included among the top collaborators of Lena Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lena Ho. Lena Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greene, Michelle K., Anitha Krishnan, Lena Ho, et al.. (2024). Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity. Pharmaceuticals. 17(11). 1443–1443. 1 indexed citations
2.
Anderson, Danielle E., Abhay P. S. Rathore, Chinmay Kumar Mantri, et al.. (2023). Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19. Journal of Clinical Investigation. 133(19). 14 indexed citations
3.
Liang, Chao, Shan Zhang, Rebecca J. Wilson, et al.. (2022). Mitochondrial microproteins link metabolic cues to respiratory chain biogenesis. Cell Reports. 40(7). 111204–111204. 26 indexed citations
4.
Lee, Cheryl, Yasir Mohamud, Gee Ann Toh, et al.. (2022). Viral proteases activate the CARD8 inflammasome in the human cardiovascular system. The Journal of Experimental Medicine. 219(10). 30 indexed citations
5.
Kuk, Alvin C. Y., Mei Ding, Cheen Fei Chin, et al.. (2022). Spns1 is a lysophospholipid transporter mediating lysosomal phospholipid salvage. Proceedings of the National Academy of Sciences. 119(40). e2210353119–e2210353119. 34 indexed citations
6.
Lee, Cheryl, Sonia Chothani, Shan Zhang, et al.. (2021). Coding and non-coding roles of MOCCI (C15ORF48) coordinate to regulate host inflammation and immunity. Nature Communications. 12(1). 2130–2130. 64 indexed citations
7.
Chen, Ying, Lena Ho, & Vinay Tergaonkar. (2020). sORF-Encoded MicroPeptides: New players in inflammation, metabolism, and precision medicine. Cancer Letters. 500. 263–270. 39 indexed citations
8.
Ho, Lena, Marie van Dijk, Daniel M. Messerschmidt, et al.. (2017). ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice. Science. 357(6352). 707–713. 168 indexed citations
9.
Ho, Lena, Shawn Y.X. Tan, Sheena Wee, et al.. (2015). ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway. Cell stem cell. 17(4). 435–447. 145 indexed citations
10.
Ho, Lena, Shawn Y.X. Tan, Sheena Wee, et al.. (2015). ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway. Cell stem cell. 17(5). 635–635. 10 indexed citations
11.
Chng, Serene C., Lena Ho, Jing Tian, & Bruno Reversade. (2013). ELABELA: A Hormone Essential for Heart Development Signals via the Apelin Receptor. Developmental Cell. 27(6). 672–680. 377 indexed citations breakdown →
12.
Kadoch, Cigall, Diana C. Hargreaves, H. Courtney Hodges, et al.. (2013). Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nature Genetics. 45(6). 592–601. 981 indexed citations breakdown →
13.
Ho, Lena, Erik L. Miller, Jehnna L. Ronan, et al.. (2011). esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function. Nature Cell Biology. 13(8). 903–913. 211 indexed citations
14.
Henry, Thomas, Girish S. Kirimanjeswara, Thomas Ruby, et al.. (2010). Type I IFN Signaling Constrains IL-17A/F Secretion by γδ T Cells during Bacterial Infections. The Journal of Immunology. 184(7). 3755–3767. 126 indexed citations
15.
Ho, Lena & Robert H. Crabtree. (2010). Chromatin remodelling during development. Nature. 463(7280). 474–484. 829 indexed citations breakdown →
16.
Ho, Lena & Robert H. Crabtree. (2008). An EZ Mark to Miss. Cell stem cell. 3(6). 577–578. 17 indexed citations
17.
Gallo, Elena, Lena Ho, Monte M. Winslow, Tracy Staton, & Robert H. Crabtree. (2008). Selective role of calcineurin in haematopoiesis and lymphopoiesis. EMBO Reports. 9(11). 1141–1148. 18 indexed citations
18.
Ho, Lena & Robert H. Crabtree. (2006). A Foxy tango with NFAT. Nature Immunology. 7(9). 906–908. 5 indexed citations
19.
Goldschmidt, Tom J., et al.. (1996). Immune Deviation during the Induction of Tolerance by way of Nasal Installation.. Annals of the New York Academy of Sciences. 778(1). 408–411. 8 indexed citations
20.
Coulson, Anne H., et al.. (1976). Evaluation of a ghetto school breakfast program. Journal of the American Dietetic Association. 68(2). 132–138. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026